In this study, nitroscanate (Lopatol tablets, Novartis) was tested for its efficacy against Toxocara canis, Toxascaris leonina and Dipylidium caninum in naturally infected dogs. Dogs that had mixed infections of cestodes and nematodes were divided into two groups: the treatment group (10 dogs) and the control group (5 dogs). Dogs in the treatment group were treated orally with a single dose of 1 tablet/10 kg of nitroscanate (50 mg/kg). After the treatment, fecal samples were examined 5 times at intervals of 2 days and it was recorded that nitroscanate removed D. caninum (4 dogs) and T. leonina (7 dogs) in all of the infected dogs and in seven of the eight dogs infected with T. canis.

In this study, nitroscanate (Lopatol tablets, Novartis) was tested for its efficacy against Toxocara canis, Toxascaris leonina and Dipylidium caninum in naturally infected dogs. Dogs that had mixed infections of cestodes and nematodes were divided into two groups: the treatment group (10 dogs) and the control group (5 dogs). Dogs in the treatment group were treated orally with a single dose of 1 tablet/10 kg of nitroscanate (50 mg/kg). After the treatment, fecal samples were examined 5 times at intervals of 2 days and it was recorded that nitroscanate removed D. caninum (4 dogs) and T. leonina (7 dogs) in all of the infected dogs and in seven of the eight dogs infected with T. canis.